Cite
Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial
MLA
Colin A. Graham, et al. “Intramuscular Midazolam, Olanzapine, or Haloperidol for the Management of Acute Agitation: A Multi-Centre, Double-Blind, Randomised Clinical Trial.” EClinicalMedicine, vol. 32, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06e575a4d92a0d02218d7ea249a0588a&authtype=sso&custid=ns315887.
APA
Colin A. Graham, Hiu-Fung Lam, Jonathan C Knott, Soo-Moi Ting, Tong-Shun Chung, Esther W. Chan, Chun-Tat Lui, Lam Lam, David C. M. Kong, Ian C. K. Wong, Chi-Pang Wong, Chi-Hung Cheng, Ling-Pong Leung, Kim S. J. Lao, David Taylor, & Sik-Hon Tsui. (2020). Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trial. EClinicalMedicine, 32.
Chicago
Colin A. Graham, Hiu-Fung Lam, Jonathan C Knott, Soo-Moi Ting, Tong-Shun Chung, Esther W. Chan, Chun-Tat Lui, et al. 2020. “Intramuscular Midazolam, Olanzapine, or Haloperidol for the Management of Acute Agitation: A Multi-Centre, Double-Blind, Randomised Clinical Trial.” EClinicalMedicine 32 (October). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06e575a4d92a0d02218d7ea249a0588a&authtype=sso&custid=ns315887.